Skip to main content
Clinical Trials/NCT04606147
NCT04606147CompletedNot Applicable

Comparison of Effectiveness of Ultrasound Guided Erector Spinae Plane Block With Ultrasound Guided Serratus Anterior Block in Modified Radical Mastectomy, Randomized Single Blinded Comparative Study.

National Cancer Institute, Egypt1 site in 1 country60 target enrollmentStarted: January 10, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Total amount of postoperative morphine consumption in 24 hours. (mg)

Study Overview

Brief Summary

The aim of this study is to compare and evaluate the safety and analgesic efficacy of ultrasound guided ESP block and ultrasound guided serratus anterior plane block in patients undergoing modified radical mastectomy.

Detailed Description

Methodology:

This Randomised Comparative Single Blinded Study was conducted at National Cancer Institute Cairo University after approval by the institutional review board, scientific committee of Anesthesia department Kasr Alainy Cairo University (02/10/2019 Code: N - 65\2019 ms) and Ethical committee at Kasr Alainy Cairo University (1\ 12 \2019 code: MS-268-2019)

Type of consent of study participants: Written and verbal

Study Methods:

Population of study: 60 Female patients ASA II, III scheduled for modified radical mastectomy under general anaesthesia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Investigator)

Masking Description

Performer of nerve blocks will know type of block but investigator for postoperative pain will be blinded

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Female patients
  • Type of surgery; Modified Radical Mastectomy MRM
  • Physical status ASA II, III.
  • Age ≥ 18 and ≤ 65 Years.
  • Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.

Exclusion Criteria

  • Age: ≤18 years or ≥65 years
  • BMI: ≤20 kg/m2 or ≥ 35 kg/m2
  • Known sensitivity or contraindication to drugs used in the study (local anaesthetics, opioids).
  • History of psychological disorders and/or chronic pain syndrome.
  • Contraindication to regional anaesthesia e.g. local sepsis, pre-existing peripheral neuropathies and coagulopathy.
  • Patient refusal.
  • Severe respiratory or cardiac disorders.
  • Advanced liver or kidney disease.
  • Pregnancy.
  • Physical status ASA IV
  • Male patients.

Outcomes

Primary Outcomes

Total amount of postoperative morphine consumption in 24 hours. (mg)

Time Frame: 24 hours

Total amount of postoperative morphine consumption in 24 hours. (mg)

Secondary Outcomes

  • Numeric Pain Rating Scale score, both at rest and during movement(24 hours)
  • Block related complications(24 hours)
  • Patient satisfaction(24 hours)
  • Change in mean arterial blood pressure intraoperatively(duration of surgery)
  • Total amount of intraoperative fentanyl consumption (mcg)(duration of surgery)
  • Change in heart rate intraoperatively(duration of surgery)
  • The degree of postoperative sedation according to Ramsay scores.(24 hours)
  • Time to first rescue analgesia (hours)(postoperative)

Investigators

Sponsor
National Cancer Institute, Egypt
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohammed Magdy Abdelrahman Elsayed

Resident of Anaesthesiology, ICU and Pain Management

National Cancer Institute, Egypt

Study Sites (1)

Loading locations...

Similar Trials